A detailed history of Modera Wealth Management, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Modera Wealth Management, LLC holds 4,844 shares of GILD stock, worth $436,880. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,844
Previous 5,315 8.86%
Holding current value
$436,880
Previous $364,000 11.54%
% of portfolio
0.01%
Previous 0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$66.59 - $83.99 $31,363 - $39,559
-471 Reduced 8.86%
4,844 $406,000
Q2 2024

Jul 29, 2024

SELL
$63.15 - $72.88 $2,020 - $2,332
-32 Reduced 0.6%
5,315 $364,000
Q1 2024

May 14, 2024

BUY
$71.58 - $87.29 $9,233 - $11,260
129 Added 2.47%
5,347 $391,000
Q4 2023

Feb 14, 2024

BUY
$73.27 - $83.09 $39,712 - $45,034
542 Added 11.59%
5,218 $422,000
Q3 2023

Nov 01, 2023

BUY
$73.94 - $80.67 $4,880 - $5,324
66 Added 1.43%
4,676 $350,000
Q2 2023

Aug 07, 2023

BUY
$76.01 - $86.7 $88,551 - $101,005
1,165 Added 33.82%
4,610 $355,000
Q1 2023

May 05, 2023

SELL
$77.31 - $88.08 $26,594 - $30,299
-344 Reduced 9.08%
3,445 $285,000
Q4 2022

Feb 07, 2023

BUY
$62.32 - $89.47 $872 - $1,252
14 Added 0.37%
3,789 $325,000
Q3 2022

Nov 01, 2022

BUY
$59.54 - $68.01 $416 - $476
7 Added 0.19%
3,775 $233,000
Q2 2022

Jul 27, 2022

SELL
$57.72 - $65.01 $1,038 - $1,170
-18 Reduced 0.48%
3,768 $233,000
Q1 2022

May 03, 2022

SELL
$57.92 - $72.58 $38,343 - $48,047
-662 Reduced 14.88%
3,786 $225,000
Q4 2021

Feb 04, 2022

BUY
$64.88 - $73.64 $2,789 - $3,166
43 Added 0.98%
4,448 $323,000
Q3 2021

Nov 04, 2021

BUY
$67.69 - $73.03 $298,174 - $321,697
4,405 New
4,405 $308,000
Q4 2018

Feb 14, 2019

SELL
$60.54 - $79.0 $161,460 - $210,693
-2,667 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$71.28 - $78.92 $190,103 - $210,479
2,667 New
2,667 $206,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $113B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Modera Wealth Management, LLC Portfolio

Follow Modera Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Modera Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Modera Wealth Management, LLC with notifications on news.